Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Indirect | 15 Added 0.05% |
$22,190
$1479.3 p/Share
|
Apr 04
2022 |
|
LLY
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct | 39,393 Reduced 0.04% |
$11,548,058
$293.15 p/Share
|
Apr 04
2022 |
|
CRM
|
Marc Benioff
Chair and CEO |
SELL
Open market or private sale
|
Direct | 2,300 Reduced 0.01% |
$501,492
$218.04 p/Share
|
Apr 04
2022 |
|
CRM
|
Marc Benioff
Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 2,300 Added 0.01% |
$186,277
$80.99 p/Share
|
Apr 04
2022 |
|
MRNA
|
Stephen Hoge
President |
SELL
Open market or private sale
|
Direct | 20,000 Reduced 1.22% |
$3,545,400
$177.27 p/Share
|
Apr 04
2022 |
|
MRNA
|
Stephen Hoge
President |
BUY
Exercise of conversion of derivative security
|
Direct | 20,000 Added 1.2% |
$19,800
$0.99 p/Share
|
Apr 04
2022 |
|
NTRA
|
Steven Leonard Chapman
CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct | 1,559 Reduced 2.44% |
$67,177
$43.09 p/Share
|
Apr 04
2022 |
|
MSP
|
Sanjay Kumar Singh
CHIEF REVENUE OFFICER |
SELL
Open market or private sale
|
Direct | 29,802 Reduced 18.13% |
$829,688
$27.84 p/Share
|
Apr 04
2022 |
|
MSP
|
Sanjay Kumar Singh
CHIEF REVENUE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 29,802 Added 15.35% |
$312,027
$10.47 p/Share
|
Apr 04
2022 |
|
MSP
|
Radhesh Balakrishnan Menon
Chief Product Officer |
SELL
Open market or private sale
|
Direct | 4,570 Reduced 82.77% |
$124,715
$27.29 p/Share
|
Apr 04
2022 |
|
MSP
|
Radhesh Balakrishnan Menon
Chief Product Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 4,570 Added 45.29% |
$58,496
$12.8 p/Share
|
Apr 04
2022 |
|
MSP
|
William Severance
CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct | 2,148 Reduced 9.76% |
$58,318
$27.15 p/Share
|
Apr 04
2022 |
|
MSP
|
William Severance
CHIEF ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct | 2,148 Added 8.9% |
$27,451
$12.78 p/Share
|
Apr 04
2022 |
|
AEI
|
Heng Fai Ambrose Chan
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 1,900,000 Added 5.66% |
$1,045,000
$0.55 p/Share
|
Apr 04
2022 |
|
BRLT
|
Jeffrey Chuenhong Kuo
Chief Financial Officer |
SELL
Other acquisition or disposition
|
Direct | 19,185 Reduced 3.37% |
-
|
Apr 04
2022 |
|
BRLT
|
Jeffrey Chuenhong Kuo
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 19,185 Reduced 17.95% |
$181,874
$9.48 p/Share
|
Apr 04
2022 |
|
BRLT
|
Jeffrey Chuenhong Kuo
Chief Financial Officer |
BUY
Conversion of derivative security
|
Direct | 19,185 Added 15.22% |
-
|
Apr 04
2022 |
|
EMAN
|
Ginola LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 35,400 Reduced 49.21% |
$40,710
$1.15 p/Share
|
Apr 04
2022 |
|
EMAN
|
Stillwater Holdings LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 35,400 Reduced 49.21% |
$40,710
$1.15 p/Share
|
Apr 04
2022 |
|
FUSN
|
John Valliant
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 700 Reduced 0.19% |
$5,467
$7.81 p/Share
|
Apr 04
2022 |
|
CDZI
|
Stephen E Courter
Director |
BUY
Open market or private purchase
|
Direct | 9,600 Added 19.32% |
$21,408
$2.23 p/Share
|
Apr 04
2022 |
|
CDZI
|
Winston H Hickox
Director |
BUY
Open market or private purchase
|
Direct | 5,385 Added 4.08% |
$11,955
$2.22 p/Share
|
Apr 04
2022 |
|
PQEFF
|
Anthony J Cantone
> 10% Shareholder |
BUY
Open market or private sale
|
Direct | 45,885 Added 0.06% |
$16,977
$0.37 p/Share
|
Apr 04
2022 |
|
FULC
|
Robert J Gould |
SELL
Open market or private sale
|
Direct | 7,235 Reduced 1.41% |
$173,785
$24.02 p/Share
|
Apr 04
2022 |
|
FULC
|
Robert J Gould |
BUY
Exercise of conversion of derivative security
|
Direct | 7,235 Added 1.39% |
$56,722
$7.84 p/Share
|
Apr 04
2022 |
|
CVLY
|
Craig L Kauffman
President & CEO |
BUY
Open market or private purchase
|
Direct | 209 Added 0.62% |
$4,598
$22.0 p/Share
|
Apr 04
2022 |
|
VRDN
|
Jonathan Violin
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 3,600 Reduced 0.66% |
$68,148
$18.93 p/Share
|
Apr 04
2022 |
|
BNFT
|
Alpana Wegner
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 5,811 Reduced 2.45% |
$73,277
$12.61 p/Share
|
Apr 04
2022 |
|
FXLV
|
Mark Wahlberg
Director |
SELL
Open market or private sale
|
Direct | 11,290 Reduced 0.51% |
$125,319
$11.1 p/Share
|
Apr 04
2022 |
|
CLVS
|
Thomas C. Harding
Officer |
SELL
Open market or private sale
|
Indirect | 7 Reduced 0.25% |
$19
$2.66 p/Share
|
Apr 04
2022 |
|
BVS
|
Alessandra Pavesio
Fmr. SVP & Chief Science Off. |
SELL
Open market or private sale
|
Direct | 32,997 Reduced 18.2% |
$368,576
$11.17 p/Share
|
Apr 04
2022 |
|
BVS
|
John Nosenzo
Fmr. Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 65,963 Reduced 44.01% |
$733,509
$11.12 p/Share
|
Apr 04
2022 |
|
BVS
|
Anthony D'Adamio
SVP & General Counsel |
SELL
Open market or private sale
|
Direct | 16,016 Reduced 28.52% |
$179,219
$11.19 p/Share
|
Apr 04
2022 |
|
ACET
|
Francesco Galimi
SVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 7,979 Reduced 11.75% |
$167,559
$21.0 p/Share
|
Apr 04
2022 |
|
ACET
|
Francesco Galimi
SVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 7,979 Added 11.45% |
$95,908
$12.02 p/Share
|
Apr 04
2022 |
|
CLW
|
Michael S Gadd
SVP, GC, Corp Secretary |
SELL
Open market or private sale
|
Direct | 2,295 Reduced 2.84% |
$63,388
$27.62 p/Share
|
Apr 04
2022 |
|
CLW
|
Kari G. Moyes
SVP, HR |
SELL
Open market or private sale
|
Direct | 4,589 Reduced 9.65% |
$126,794
$27.63 p/Share
|
Apr 04
2022 |
|
CDLX
|
Scott D. Grimes
Director |
SELL
Open market or private sale
|
Direct | 6,000 Reduced 2.6% |
$343,800
$57.3 p/Share
|
Apr 04
2022 |
|
POSH
|
Manish Chandra
President and CEO |
SELL
Open market or private sale
|
Direct | 2,109 Reduced 22.42% |
$26,763
$12.69 p/Share
|
Apr 04
2022 |
|
POSH
|
John Michael Mc Donald
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 3,162 Reduced 3.55% |
$40,126
$12.69 p/Share
|
Apr 04
2022 |
|
ENTA
|
Nathalie Adda
Sr. VP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 32,785 Reduced 48.38% |
$2,363,143
$72.08 p/Share
|
Apr 04
2022 |
|
ENTA
|
Nathalie Adda
Sr. VP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 32,785 Added 32.61% |
$1,698,591
$51.81 p/Share
|
Apr 04
2022 |
|
SNDX
|
Briggs Morrison |
SELL
Open market or private sale
|
Direct | 3,128 Reduced 14.92% |
$57,211
$18.29 p/Share
|
Apr 04
2022 |
|
SNDX
|
Briggs Morrison |
BUY
Exercise of conversion of derivative security
|
Direct | 3,128 Added 12.98% |
$34,095
$10.9 p/Share
|
Apr 04
2022 |
|
ISEE
|
David Francis Carroll
SVP, Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 20,316 Added 20.03% |
$29,458
$1.45 p/Share
|
Apr 04
2022 |
|
ISEE
|
David Francis Carroll
SVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 40,941 Reduced 50.48% |
$767,644
$18.75 p/Share
|
Apr 04
2022 |
|
AGYS
|
Kyle C Badger
SVP, GC and Secretary |
SELL
Open market or private sale
|
Direct | 378 Reduced 0.41% |
$15,434
$40.83 p/Share
|
Apr 04
2022 |
|
AGYS
|
Prabuddha Biswas
CTO & SVP of Technology |
SELL
Open market or private sale
|
Direct | 315 Reduced 0.41% |
$12,861
$40.83 p/Share
|
Apr 04
2022 |
|
AGYS
|
Donald Anthony De Marinis
Senior Vice President of Sales |
SELL
Open market or private sale
|
Direct | 369 Reduced 3.53% |
$15,066
$40.83 p/Share
|
Apr 04
2022 |
|
AGYS
|
Jebaseelan Kingsley
VP, Professional Services |
SELL
Open market or private sale
|
Direct | 322 Reduced 1.49% |
$13,147
$40.83 p/Share
|
Apr 04
2022 |